Re: Vaccine PSUs closure in India: info on PII Coonoor:Attn:Dr Santosh

[Guest guest]

Dear Dr. Santosh and NETRUMians,

The fact that the PSUs are sanctioned crores of Rs for purchasing the seeds for measles vaccine production and the free distribution to private firm leads to suspect about misappropriation of the Taxpayers Fund by Govt officials. But it still need more clarification. They (govt) will have some justification (False?) for it too.

It is really interesting that the PSU which distributed the seeds free to private firms dont make it available to its fellow PSU.

Welldone Dr Santosh for such valuable input.

Regards,

Dr Kiran D Cahudhari

Lecturer,

Dept of Pharmacology,

Govt Medical College,

Nagpur.>> Dear NETRUMians,> > Following information on Pastuer Institute of India Coonoor is copied for fare use and is also available on this link given below. > http://www.pasteuri nstituteindia. com/home. htm> > About Us> Pasteur Institute of India, Coonoor is one of the leading Institute in the production of Anti-rabies Vaccine for the Expanded Programme of Immunization of Govt. of India. This Institute started functioning as Pasteur Institute of Southern India, on April 6, 1907 and the Institute took a new birth as the Pasteur Institute of India (registered as a society under the Societies Registration Act 1860) and started functioning as an autonomous body under the Ministry of Health and Family Welfare, Government of India, New Delhi from the February 10, 1977. The affairs of the institute are managed by a governing body.> > The institute is a charitable organization working on no profit - no loss basis. > > Right to Information

Act > > a) Name and Designation with Telephone No. of Officer appointed as Central Public Information Officer(CPIO) of Pasteur Institute of India, Coonoor > > Dr. N. Elangeswaran > Director > Pasteur Institue of Inida, Coonoor, 643103, Nilgiris > Tel. No. 0423-2231250, 2231846 > > Appellate Authority > The Secretary to Govt of India, authority of Health and Family Welfare, New Delhi 110011 > (Ex- Office chairman of the Governing Body of Pasteur Institute of India, Coonoor) > > Technology> We have consistently set the pace in innovating and adapting technology to suit Indian conditions and needs. It is this vast experience and expertise which makes it well equipped to meet the challenges of applying advanced technology in vaccine production. Among the major equipments available in the Institute are large bacterial

fermentors, Zonal ultra centrifuge, freeze drier, several bulk autoclaves, Hot-air ovens, filling machines, large cold rooms and deep freezers etc. Full fledged facility is available for Research and Development work which includes radioisotope handling and all related equipments FPLC system, ultra centrifuge, ELISA reader and equipment for molecular biology work.> > The Institute is recognized by the Tamilnadu Dr. M. G. R. Medical University, Madras for M.D degree in Microbiology and by the Bharathiyar University, Coimbatore for Ph.D. Degree in Microbiology in the faculty of Science.> > The Institute has a well -faciliated library also. The Library is one of the best libraries in the South India. It is a special library with limited number of essential books in the field of Vaccinology, Biotechnology, Pharmacology and Microbiology. For mot of the periodical titles, back volumes

are available from 1950 and for few 1920 onwards. Many scientist and trainees from various institutions utilize the library facilities. The library has stocked with 4192 books and 12022 bound volumes, 16 International journals, 14 Indian Journals and WHO Publications (Global subscription) . > > Objectives & Activities> > Production> DTP group vaccines. > â— DPT Vaccine > â— DT Vaccine > â— TT Vaccine > Vero Cell Derived Rabies Vaccine for Human use. > Tissue culture Anti Rabies Vaccine for Animals. > > R & D> Cost effective Tissue Culture Rabies Vaccine.> Tissue Culture based cost effective JE Vaccine. >

Training Programmes and Post-graduate activities.> Consultancy services to Scientists of other Institutions within the country and abroad.> Establishing of WHO Collaborating Centre for Training in rabies Vaccine Production and Quality Control.> Academic Programmes ( Bharathiar University, Coimbatore for Ph.D and Tamilnadu, Dr. M. G. R. Medical University, Madras for M.D.)> Cost Effective Newer Vaccines/Sera.> Training in Vaccine manufacture/ Biotechnology.> Enterovirus laboratory for cold chain monitoring of Oral Polio Vaccine and surveillance of paralytic poliomyelitis; and Government Analyst for testing OPV.> > Other Activities> Rabies Diagnostic Laboratory.> Dog/Animal bite Treatment Centre (24 hours service for emergency cases).> National Polio

Laboratory for Surveillance of AFP Cases. > > > Milestones> > 1907 Manufacture of Neural Tissue Antirabies Vaccine.> > 1957 Isolation of Asian Flue Virus during the pandemic and development of Influenza vaccine against the same virus.> > 1970 For the first time in India PII, Coonoor developed, produced and supplied BPL inactivated Rabies Vaccine, which made > the treatment easier, cheaper with less dose, injections and side effects with a vaccine of increased potency.> > 1970 For the first time in India, PII Coonoor developed and produced indigenous Oral Polio Vaccine Trivalent (Sabin).> > 1982 Production of DPT group of

vaccines for the National Programme of Immunization.> > 1988 Production of Tissue Culture Rabies Vaccine for Canine Prophylaxis, a milestone in the control of rabies.> > 2001 For the first time in India PII, Coonoor, amongst Government controlled Institutions, developed and released > Vero Cell Derived DNA purified Rabies Vaccine for human use at an affordable price to common man.> Achievements> > Research work on Rabies, Influenza, Adeno and other viruses, introduction of BPL inactivated brain tissue rabies vaccine for the first time in the country in the year 1970, production and release of more than one million doses of totally indigenous Oral Polio Vaccine, Substantial contribution of DTP Vaccines every year to the

National Programme of Immunization and development of Vero Cell based vaccine for humans and canines by indigenous technology.> > The Institute’s dream is to be a model Institute with the introduction of modern processes and latest GMP facilities and be a leader in vaccinology in the country.> > > Future Plan> > Scaling up and providing cGMP facilities for the production of DPT group of Vaccines.> > Scaling up and providing cGMP facilities for the production of Tissue Culture Antirabies Vaccine.> > Research and development of liquid tissue culture Rabies vaccine production to bring down the cost.> > Research and development of state of the art chromatorgraphy purification system to produce DNA free freeze dried vaccine> culture rabies vaccine.> >

Research and development of newer cost effective vaccines like Quardruple vaccine (Hepatitis-B + DPT vaccine) and Vero cell derived inactivated purified Japanese Encephalitis vaccine for humans.> > New facilities for production of newer Viral and Bacterial Vaccines with cGMP facilities and R & D at Coimbtore.> > > Regards,> > Dr Kiran Chaudhari> Lecturer,> Dept of Pharmacology,> GMC, Nagpur> > > Unlimited freedom, unlimited storage. Get it now, on http://help. / l/in// mail/mail/ tools/tools- 08.html/>

Unlimited freedom, unlimited storage. Get it now

[Guest guest]

Dear Netrumians,

" Save Pasteur Institute of India " , an action forum formed by its

scientists and staff to protest against the closure of vaccine

production at the PSU, has alleged that 15 persons were trained in

vaccine production at the PSU. After completion of their training,

they were absorbed by Green Signal Bio Pharma, owned by

Sundaraparipoornan, it alleged. The CPI(M) MP from Madurai, P Mohan,

has alleged that Sundaraparipoornan is a close associate of Union

Health Minister Anbumani Ramadoss.

Before the Union Health Ministry ordered three Public Sector

Undertakings (PSUs) to stop vaccine production, at least one of them

recruited and trained a batch of scientists who defected overnight

to private manufacturer Green Signal Bio Pharma.

The case shows that apart from helping the private company avail a

bank loan for starting vaccine production, the PSUs were also used

to train the workforce of the private company.

According to the association, the PSU had released an advertisement

on September 13, 2006, in all leading dailies to seek the

recruitment of senior and junior research fellows. " Dr

Elangeshwaran, the then director, supervised the entire recruiting

process and selected 15 persons, who were on February 12, 2007,

posted with the Pasteur Institute, " said the action forum.

All the candidates selected were residents of or near Chennai. " The

entire batch was posted in the vaccine production department, the

most critical area of the unit. Pasteur Institute's training is the

best in the country and Elangeshwaran personally monitored the

training of this particular batch, " the action forum pointed out.

" On September 21, 2007, the entire batch went missing from the

Pasteur Institute premises. As per service rules, it is a clear case

of unauthorised absence. Though other scientists reported the matter

to Elangeshwaran, no action was taken, " the forum alleged. It added

that the entire batch of senior research fellows and junior research

fellows, which acquired the training in vaccine production at the

PSU, is now working with Green Signal Bio Pharma's vaccine

production unit. " This incident shows how the Government-appointed

authorities helped private vaccine manufactures in a well-planned

manner by murdering the prestigious PSU, " said the action forum.

Dr Elangeshwaran, the then director who had implemented the Health

Ministry's order to close down vaccine manufacture by the two PSUs,

now says that he did all that under pressure from his seniors in the

Health Ministry.

This clearly shows the direct involvement of the ministry!!!

Dr.Santosh

In netrum , kiran chaudhari <kiranchaudhari7@...>

wrote:

>

> Dear Dr. Santosh and NETRUMians,

>  

> The fact that the PSUs are sanctioned crores of Rs for purchasing

the seeds for measles vaccine production and the free distribution

to private firm leads to suspect about misappropriation of the

Taxpayers Fund by Govt officials. But it still need more

clarification. They (govt) will have some justification (False?) for

it too.

>  

> It is really interesting that the PSU which distributed the

seeds free to private firms dont make it available to its fellow PSU.

>  

> Welldone Dr Santosh for such valuable input.

>  

> Regards,

> Dr Kiran D Cahudhari

> Lecturer,

> Dept of Pharmacology,

> Govt Medical College,

> Nagpur.

>

>

> >

> > Dear NETRUMians,

> >  

> > Following information on Pastuer Institute of India Coonoor is

> copied for fare use and is also available on this link given

below.

> > http://www.pasteuri nstituteindia. com/home. htm

> >  

> > About Us

> > Pasteur Institute of India, Coonoor is one of the leading

> Institute in the production of Anti-rabies Vaccine for the

Expanded

> Programme of Immunization of Govt. of India. This Institute

started

> functioning as Pasteur Institute of Southern India, on April 6,

1907

> and the Institute took a new birth as the Pasteur Institute of

India

> (registered as a society under the Societies Registration Act

1860)

> and started functioning as an autonomous body under the Ministry

of

> Health and Family Welfare, Government of India, New Delhi from the

> February 10, 1977. The affairs of the institute are managed by a

> governing body.

> >

> > The institute is a charitable organization working on no profit -

> no loss basis.

> >

> > Right to Information Act

> >

> > a) Name and Designation with Telephone No. of Officer appointed

as

> Central Public Information Officer(CPIO) of Pasteur Institute of

> India, Coonoor

> >

> > Dr. N. Elangeswaran

> > Director

> > Pasteur Institue of Inida, Coonoor, 643103, Nilgiris

> > Tel. No. 0423-2231250, 2231846

> >

> > Appellate Authority

> > The Secretary to Govt of India, authority of Health and Family

> Welfare, New Delhi 110011

> > (Ex- Office chairman of the Governing Body of Pasteur Institute

of

> India, Coonoor)

> >  

> > Technology

> > We have consistently set the pace in innovating and adapting

> technology to suit Indian conditions and needs. It is this vast

> experience and expertise which makes it well equipped to meet the

> challenges of applying advanced technology in vaccine production.

> Among the major equipments available in the Institute are large

> bacterial fermentors, Zonal ultra centrifuge, freeze drier,

several

> bulk autoclaves, Hot-air ovens, filling machines, large cold rooms

> and deep freezers etc. Full fledged facility is available for

> Research and Development work which includes radioisotope handling

> and all related equipments FPLC system, ultra centrifuge, ELISA

> reader and equipment for molecular biology work.

> >

> > The Institute is recognized by the Tamilnadu Dr. M. G. R.

Medical

> University, Madras for M.D degree in Microbiology and by the

> Bharathiyar University, Coimbatore for Ph.D. Degree in

Microbiology

> in the faculty of Science.

> >

> > The Institute has a well -faciliated library also. The Library

is

> one of the best libraries in the South India. It is a special

> library with limited number of essential books in the field of

> Vaccinology, Biotechnology, Pharmacology and Microbiology. For mot

> of the periodical titles, back volumes are available from 1950 and

> for few 1920 onwards. Many scientist and trainees from various

> institutions utilize the library facilities. The library has

stocked

> with 4192 books and 12022 bound volumes, 16 International

journals,

> 14 Indian Journals and WHO Publications (Global subscription) .

> >  

> > Objectives & Activities

> >

> > Production

> >   DTP group vaccines.

> >           â—  DPT Vaccine

> >           â—  DT Vaccine

> >           â—  TT Vaccine

> >   Vero Cell Derived Rabies Vaccine for Human use.

> >   Tissue culture Anti Rabies Vaccine for Animals.

> >

> > R & D

> >   Cost effective Tissue Culture Rabies Vaccine.

> >   Tissue Culture based cost effective JE Vaccine.

> >   Training Programmes and Post-graduate activities.

> >   Consultancy services to Scientists of other Institutions

within

> the country and abroad.

> >   Establishing of WHO Collaborating Centre for Training in

rabies

> Vaccine Production and Quality Control.

> >   Academic Programmes ( Bharathiar University, Coimbatore for

> Ph.D and Tamilnadu, Dr. M. G. R. Medical University, Madras for

M.D.)

> >   Cost Effective Newer Vaccines/Sera.

> >   Training in Vaccine manufacture/ Biotechnology.

> >   Enterovirus laboratory for cold chain monitoring of Oral

Polio

> Vaccine and surveillance of paralytic poliomyelitis; and

Government

> Analyst for       testing OPV.

> >

> > Other Activities

> >   Rabies Diagnostic Laboratory.

> >   Dog/Animal bite Treatment Centre (24 hours service for

> emergency cases).

> >   National Polio Laboratory for Surveillance of AFP Cases.

> >  

> >  

> > Milestones

> >

> > 1907     Manufacture of Neural Tissue Antirabies Vaccine.

> >

> > 1957     Isolation of Asian Flue Virus during the pandemic

and

> development of Influenza vaccine against the same virus.

> >

> > 1970     For the first time in India PII, Coonoor developed,

> produced and supplied BPL  inactivated Rabies Vaccine, which made

> >               the treatment easier, cheaper with

less

> dose, injections and side effects with a vaccine of increased

> potency.

> >

> > 1970     For the first time in India, PII Coonoor developed

> and produced indigenous Oral Polio Vaccine Trivalent (Sabin).

> >

> > 1982     Production of DPT group of vaccines for the

National

> Programme of Immunization.

> >

> > 1988     Production of Tissue Culture Rabies Vaccine for

> Canine Prophylaxis, a milestone in the control of rabies.

> >

> > 2001      For the first time in India PII, Coonoor, amongst

> Government controlled Institutions, developed and released

> >                Vero Cell Derived DNA purified

Rabies

> Vaccine for human use at an affordable price to common man.

> > Achievements

> >

> > Research work on Rabies, Influenza, Adeno and other viruses,

> introduction of BPL inactivated brain tissue rabies vaccine for

the

> first time in the country in the year 1970, production and release

> of more than one million doses of totally indigenous Oral Polio

> Vaccine, Substantial contribution of DTP Vaccines every year to

the

> National Programme of Immunization and development of Vero Cell

> based vaccine for humans and canines by indigenous technology.

> >

> > The Institute’s dream is to be a model Institute with the

> introduction of modern processes and latest GMP facilities and be

a

> leader in vaccinology in the country.

> >

> >

> > Future Plan

> >

> >   Scaling up and providing cGMP facilities for the production

of

> DPT group of Vaccines.

> >

> >   Scaling up and providing cGMP facilities for the production

of

> Tissue Culture Antirabies Vaccine.

> >

> >   Research and development of liquid tissue culture Rabies

> vaccine production to bring down the cost.

> >

> >   Research and development of state of the art chromatorgraphy

> purification system to produce DNA free freeze dried vaccine

> >     culture  rabies  vaccine.

> >

> >   Research and development of newer cost effective vaccines

like

> Quardruple vaccine (Hepatitis-B + DPT vaccine) and Vero cell

derived

> inactivated     purified Japanese Encephalitis vaccine for

> humans.

> >

> >   New facilities for production of newer Viral and Bacterial

> Vaccines with cGMP facilities and R & D at  Coimbtore.

> >  

> >  

> > Regards,

> >  

> > Dr Kiran Chaudhari

> > Lecturer,

> > Dept of Pharmacology,

> > GMC, Nagpur

> >

> >

> > Unlimited freedom, unlimited storage. Get it now, on

> http://help. / l/in// mail/mail/ tools/tools-

08.html/

> >

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

> Check out the all-new face of India. Go to

http://in./

>